ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

INZY Company Profile and Key Details

NASDAQ : INZY

Inozyme Pharma, Inc.

$1.15

-0.08-6.50%

At Close 4:00 PM

69.54

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

INZY Stock Price Chart

Stock Price Today

Inozyme Pharma, Inc. (INZY) stock declined over -6.50%, trading at $1.15 on NASDAQ, down from the previous close of $1.23. The stock opened at $1.25, fluctuating between $1.13 and $1.28 in the recent session.

Stock Snapshot

1.23

Prev. Close

1.25

Open

73.88M

Market Cap

64.24M

Number of Shares

1.13

Day Low

1.28

Day High

-0.74

P/E Ratio

67.8%

Free Float in %

-1.55

EPS (TTM)

2.27

Book Value

-1.15

Cash Flow per Share

415.84K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	1.25	1.29	1.13	1.15	414.63K
Mar 06, 2025	1.17	1.25	1.16	1.23	572.27K
Mar 05, 2025	1.10	1.20	1.10	1.19	461.31K
Mar 04, 2025	1.07	1.17	1.04	1.12	488.11K
Mar 03, 2025	1.23	1.27	1.09	1.09	453.73K
Feb 28, 2025	1.19	1.22	1.16	1.20	491.61K
Feb 27, 2025	1.22	1.28	1.19	1.20	427.7K
Feb 26, 2025	1.17	1.25	1.17	1.21	583.1K
Feb 25, 2025	1.24	1.27	1.19	1.19	602.04K
Feb 24, 2025	1.25	1.30	1.21	1.24	871.62K
Feb 21, 2025	1.30	1.31	1.25	1.25	705.24K
Feb 20, 2025	1.31	1.32	1.26	1.27	663.69K
Feb 19, 2025	1.32	1.35	1.31	1.31	521.25K
Feb 18, 2025	1.39	1.42	1.31	1.32	583.03K
Feb 14, 2025	1.37	1.43	1.33	1.37	427.32K
Feb 13, 2025	1.38	1.38	1.27	1.35	549.02K
Feb 12, 2025	1.28	1.37	1.24	1.35	525.42K
Feb 11, 2025	1.40	1.42	1.27	1.29	720.6K
Feb 10, 2025	1.45	1.49	1.37	1.40	697.94K
Feb 07, 2025	1.50	1.52	1.44	1.45	405.2K

Contact Details

Boston, MA 02210

United States

Website: https://www.inozyme.comContact: 857 330 4340

About Company

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Frequently Asked Questions

What is the current Inozyme Pharma, Inc. (INZY) stock price?

Inozyme Pharma, Inc. (NASDAQ: INZY) stock price is $1.15 in the last trading session. During the trading session, INZY stock reached the peak price of $1.28 while $1.13 was the lowest point it dropped to. The percentage change in INZY stock occurred in the recent session was -6.5% while the dollar amount for the price change in INZY stock was -$0.08.

INZY's industry and sector of operation?

The NASDAQ listed INZY is part of Biotechnology industry that operates in the broader Healthcare sector. Inozyme Pharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INZY?

Dr. David Thompson M.A., M.S., Ph.D.
Senior Vice President, Chief Scientific Officer & Chief Devel. Officer
Dr. Soojin Kim Ph.D.
Senior Vice President & Chief Technical Operations Officer
Dr. Yves Sabbagh Ph.D.
Chairman of Scientific Advisory Board & Senior Vice President
Mr. Henric Bjorn Bjarke
Consultant
Dr. Matthew Winton Ph.D.
Senior Vice President & Chief Operating Officer
Mr. Sanjay S. Subramanian M.B.A., M.S.
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Ms. Gayle Gironda
Senior Vice President & Chief People Officer
Mr. Stefan Riley
Director of Investor Relations
Mr. Axel Bolte M.B.A., M.Sc.
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Demetrios Braddock M.D., Ph.D.
Co-Founder, Scientific Founder, Member of Scientific Advisory Board & Board Observer
Dr. Douglas A. Treco Ph.D.
Chief Executive Officer & Chairman
Dr. Kurt C. Gunter FASCP, M.D., Ph.D.
Chief Medical Officer

How INZY did perform over past 52-week?

INZY's closing price is 10.58% higher than its 52-week low of $1.04 where as its distance from 52-week high of $7.80 is -85.25%.

How many employees does INZY have?

Number of INZY employees currently stands at 59.

Link for INZY official website?

Official Website of INZY is: https://www.inozyme.com

How do I contact INZY?

INZY could be contacted at phone 857 330 4340 and can also be accessed through its website. INZY operates from 321 Summer Street, Boston, MA 02210, United States.

How many shares of INZY are traded daily?

INZY stock volume for the day was 415.84K shares. The average number of INZY shares traded daily for last 3 months was 735.66K.

What is the market cap of INZY currently?

The market value of INZY currently stands at $73.88M with its latest stock price at $1.15 and 64.24M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	59
Beta	1.31
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology